We are excited to announce that Sonio, the pioneering company committed to transforming women's healthcare through innovative technological solutions, has successfully raised $4 million in its latest funding round. This significant investment will be instrumental in further enhancing Sonio’s next-generation Women’s Health Practice Management and Reporting Software, which is designed to empower ultrasound practitioners, clinical executives, and IT teams. With the power of Artificial Intelligence, particularly through our FDA 510(k) cleared Sonio Detect product and MDR-CE marked Sonio Expert product, our platform ensures that every prenatal examination meets the highest quality standards. This funding will enable us to expand our product capabilities, enhance user experience, and drive extensive marketing efforts to reach more healthcare providers committed to excellence in prenatal care. As we continue to improve efficiency, quality assurance, and clinical outcomes throughout the patient's pregnancy journey, Sonio remains dedicated to supporting practitioners in delivering exceptional care. We thank our investors for their belief in our mission and look forward to the impactful advancements that will benefit healthcare providers and expectant families alike. Together, we will revolutionize women’s health and create a brighter, healthier future for mothers and their babies.
Sonio Secures $4 Million in Seed Funding to Revolutionize Women's Health Management Software
Get the full Sonio company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
White Circle
White Circle is the control layer for AI in production. We help companies test, protect, observe, and improve every AI interaction — from blocking unsafe inputs and preventing jailbreaks to analyzing user behavior and optimizing model performance.
$11.0M Seed
today
Hoplon AI
Human Convesation, Super Human Protection - Always on
$1.0M Seed
today
Isomorphic Labs
Isomorphic Labs is here to advance human health by building on and beyond the Nobel-winning AlphaFold system. Our interdisciplinary team has developed a unified, state-of-the-art drug design engine that will transform how we design new drugs, and ultimately change the way medicine will help and heal people. Every day, and with each new breakthrough, we’re getting closer to achieving our ambitious mission to one day solve all disease
$2.1B Series b
today
Sensible Medical Innovations Ltd.
Sensible Medical has developed a non-invasive fluid status monitor (ReDS) for accurate measurement and monitoring of lung fluid for heart failure patients.
$20.0M Unknown
today
Replenish, Inc.
Replenish, Inc. developed the world's smallest implantable, refillable drug pump for the $7 billion retinal therapeutic market (pump currently in clinical investigation, not yet approved by FDA for sale). The MicroPump is implanted under the eye's skin for the purpose of periodically injecting sight-saving medication for patients with age related macular degeneration (AMD). After a 20 minute outpatient surgical procedure, the pump is programmed and recharged wirelessly by the physician and refilled ever 6 months to deliver biotech protein therapies that could only be otherwise administered by a physician's syringe every 4 weeks for life. See our website at www.replenishinc.com for more information.
$100.0K Unknown
today
Other recent Seed rounds
Companies that recently closed a Seed round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 | White Circle | Seed | $11.0M | today |
| 2 | Hoplon AI United Kingdom | Seed | $1.0M | today |
| 3 |  YachtLife: Yacht Brokerage United States | Seed | $1.0M | today |
| 4 |  Kerning Cultures Network | Seed | $500.0K | today |
| 5 |  Gather Voices United States | Seed | $1.1M | today |